Microsoft Corporation
$3.62T- Market cap
- $3.65T
- Debt
- +$49.52B
- Cash
- −$76.84B
Capital structure 99% equity / 1% debt · EV / Revenue 10.92x · EV / EBITDA 17.68x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MSFT stock price at discount vs IOVA $491.74 current versus $664.51 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at IOVA's multiple
Implied fair value · at MSFT's multiple
Snapshot Sep 8, 10:02 AM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: MSFT FY 2026 (ended Jun 30, 2026) · IOVA FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 99% equity / 1% debt · EV / Revenue 10.92x · EV / EBITDA 17.68x
Capital structure 100% equity / 0% debt · EV / Revenue 13.75x
MSFT carries the larger enterprise value at $3.62T against $3.62B; MSFT trades on the lower EV / Revenue multiple (10.92x vs 13.75x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MICROSOFT CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
IOVANCE BIOTHERAPEUTICS, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.11x
0.00x
Net debt / EBITDA
Leverage against operating earnings
-0.13x
0.83x
Cash and equivalents
Liquid reserves on the balance sheet
$76.84B
$296.98M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Apple Inc.
MSFT vs AAPL
Alphabet Inc.
MSFT vs GOOGL
AMAZON COM INC
MSFT vs AMZN
ADOBE INC.
MSFT vs ADBE
NVIDIA CORP
MSFT vs NVDA
CISCO SYSTEMS, INC.
MSFT vs CSCO
BioNTech SE
MSFT vs BNTX
Moderna, Inc.
MSFT vs MRNA
GILEAD SCIENCES, INC.
MSFT vs GILD
Legend Biotech Corp
MSFT vs LEGN
$49.52B
$1.00M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.